title: Tuberculin testing and risk of tuberculosis infection among New York City schoolchildren.
abstract: OBJECTIVE
  To assess adherence to a 1996 health policy change, which discontinued mandatory tuberculin skin testing (TST) of new entrants to NYC primary schools and continued mandatory testing of new entrants to secondary schools.
  
  
  METHODS
  The proportion tested before (1991-1995) and after (1996-1998) the change in health policy was determined. Factors associated with TST positivity and the cost of continued testing were assessed.
  
  
  RESULTS
  A total of 76.6% of 551 636 new entrants to primary schools were tested in 1991-1995; slightly fewer, 71.1% of 339 958, were tested in 1996- 1998. Among new entrants to secondary schools, 31.0% of 106 463 were tested in 1991-1995 and 51.4% of 53 762 were tested in 1996-1998. The proportion who were TST-positive continued to decrease after 1996 to 1.2% among primary and 9.7% among secondary schoolchildren in 1998. Older age and birth outside the United States were associated with TST positivity. The estimated minimum cost of continued testing in primary schools was $123 152 per tuberculosis case prevented.
  
  
  CONCLUSIONS
  An approach aimed at reducing testing of children at low risk for latent tuberculosis infection did not decrease testing of younger children. More important, older children who were more likely to be born in countries of high tuberculosis incidence were not tested. Additional efforts are needed to increase awareness among medical and school personnel to decrease testing among children who do not have risk factors for latent tuberculosis infection and to increase tuberculin testing of children who are entering school for the first time at the secondary level and do have risk factors for tuberculosis infection.
authors.affiliation: Tuberculosis Control Program, New York City Department of Health, New York, New York 10007, USA.
authors.forename: Celine R
authors.initials: CR
authors.lastname: Gounder
authors.forename: Cynthia R
authors.initials: CR
authors.lastname: Driver
authors.forename: Jerod N
authors.initials: JN
authors.lastname: Scholten
authors.forename: Huimin
authors.initials: H
authors.lastname: Shen
authors.forename: Sonal S
authors.initials: SS
authors.lastname: Munsiff
mesh_terms: D000293:Adolescent; D001500:BCG Vaccine / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D000075202:Contraindications; D004641:Emigration and Immigration / Q000706:statistics & numerical data; D006801:Humans; D017589:Immunization Programs / Q000379:methods / Q000706:statistics & numerical data; D008403:Mass Screening / Q000191:economics / Q000379:methods / Q000706:statistics & numerical data; D015999:Multivariate Analysis; D009169:Mycobacterium tuberculosis / Q000276:immunology / Q000302:isolation & purification; D009519:New York City / Q000453:epidemiology; D015995:Prevalence; D012307:Risk Factors; D012959:Socioeconomic Factors; D014374:Tuberculin Test / Q000191:economics / Q000379:methods / Q000706:statistics & numerical data*; D014376:Tuberculosis / Q000175:diagnosis / Q000453:epidemiology* / Q000208:ethnology / Q000517:prevention & control
chemical_list: D001500:BCG Vaccine